International Journal of Rheumatic Diseases
Scope & Guideline
Cultivating knowledge for a healthier future.
Introduction
Aims and Scopes
- Clinical Research in Rheumatic Diseases:
The journal publishes original research focused on the clinical aspects of rheumatic diseases, including treatment outcomes, patient management strategies, and the evaluation of therapeutic interventions. - Experimental and Translational Research:
Research that explores the underlying mechanisms of rheumatic diseases, including genetic, immunological, and environmental factors, is a key focus area, aiming to translate findings into clinical practice. - Epidemiological Studies:
The journal includes studies that examine the prevalence, incidence, and risk factors associated with rheumatic diseases, contributing to a better understanding of these conditions in different populations. - Innovative Therapeutic Approaches:
Research on new pharmacological treatments, including biologics and targeted therapies, as well as traditional and complementary medicine approaches, is highlighted. - Patient-Centered Care:
The journal emphasizes research that improves patient quality of life, including studies on psychosocial aspects, healthcare utilization, and patient education. - Multidisciplinary Approaches:
The journal encourages interdisciplinary research that involves collaboration among rheumatologists, immunologists, physiotherapists, and other healthcare professionals to optimize patient outcomes.
Trending and Emerging
- Impact of COVID-19 on Rheumatic Diseases:
A significant number of studies are focusing on the effects of COVID-19 on patients with rheumatic diseases, including vaccine responses, disease flares, and management strategies during the pandemic. - Biologics and Targeted Therapies:
There is an increasing emphasis on research related to the efficacy, safety, and long-term outcomes of biologic therapies and JAK inhibitors, reflecting the ongoing evolution of treatment paradigms in rheumatology. - Microbiome and Autoimmunity:
Emerging research is exploring the relationship between gut microbiota and autoimmune diseases, suggesting potential therapeutic targets and new insights into disease pathogenesis. - Personalized Medicine in Rheumatology:
Studies focusing on personalized approaches to treatment based on genetic, environmental, and clinical factors are becoming more prevalent, emphasizing the need for tailored therapies. - Patient-Reported Outcomes and Quality of Life:
There is a growing focus on understanding patient-reported outcomes and quality of life measures, reflecting an increasing recognition of the importance of patient-centered care in rheumatology. - Multimorbidity and Comorbid Conditions:
Research exploring the intersection of rheumatic diseases with other chronic conditions, such as cardiovascular disease and diabetes, is gaining importance as it impacts treatment strategies and patient management.
Declining or Waning
- Traditional Therapeutic Approaches:
Research on conventional treatments, such as non-steroidal anti-inflammatory drugs (NSAIDs) and older disease-modifying anti-rheumatic drugs (DMARDs), has seen a decrease, likely overshadowed by the rapid development of biologics and JAK inhibitors. - Basic Science without Clinical Application:
Studies focused purely on basic science findings, without clear pathways to clinical application or relevance to patient care, seem to be less frequently published, indicating a shift towards more translational research. - Single-Center Studies:
The prevalence of single-center studies is declining, as there is a growing emphasis on multicenter, larger scale studies that offer broader insights and greater generalizability to findings. - Descriptive Epidemiological Studies:
While epidemiological research remains important, there appears to be a decline in purely descriptive studies that do not incorporate advanced analytical methods or novel insights into disease mechanisms.
Similar Journals
RMD Open
Elevating the standards of health research and practice.RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.
Acta Reumatologica Portuguesa
Exploring the frontiers of rheumatology and general medicine.Acta Reumatologica Portuguesa is a premier open access journal dedicated to the field of rheumatology and general medicine, published by PUBLISAUDE-EDICOES MEDICAS LDA since its inception in 1973. Situated in Portugal, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the understanding and management of rheumatic diseases. Despite its current Q4 ranking in both Medicine (miscellaneous) and Rheumatology, it serves as a vital platform for researchers and professionals aiming to share innovative insights and clinical practices within a rapidly evolving field. Researchers and medical professionals will find valuable information that can significantly influence their work, given the journal’s commitment to accessible knowledge through its open access model. By prioritizing collaboration and knowledge-sharing, Acta Reumatologica Portuguesa continues to engage with issues of critical relevance in rheumatology, appealing to a diverse audience of scholars and healthcare practitioners.
Lupus Science & Medicine
Advancing lupus research for a healthier tomorrow.Lupus Science & Medicine is a leading open-access journal published by the BMJ Publishing Group, dedicated to advancing the understanding and treatment of lupus and related autoimmune diseases. Since its establishment in 2014, the journal has fostered an academic environment for researchers, healthcare professionals, and students, providing a platform for high-quality, evidence-based studies. With a notable impact in the fields of immunology and rheumatology, it currently holds a Q1 ranking in Rheumatology and Medicine (miscellaneous) and Q2 in Immunology, reflecting its significant contribution to these vital areas of medical research. The journal is indexed in Scopus, with a commendable rank in the 67th percentile for Rheumatology, making it a valuable resource for those seeking the latest insights into lupus management and treatment. The journal emphasizes the importance of open access, ensuring that research findings are widely available to enhance global knowledge and collaboration in the fight against lupus.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Fostering collaboration through rigorous research and case studies.Rheumatic Disease Clinics of North America is a premier journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of rheumatology through comprehensive and impactful research. With an ISSN of 0889-857X and an E-ISSN of 1558-3163, this esteemed publication has been disseminating knowledge since its inception in 1987, and continues to guide clinicians and researchers alike through its insightful articles and case studies. Positioned in the 2023 Q2 quartile for Rheumatology, it ranks #31 out of 73 journals in the Scopus category of Medicine _ Rheumatology, reflecting a commendable impact factor and relevance in the academic community. Although it does not offer open access options, the journal ensures that subscribers have access to cutting-edge research and reviews that address contemporary challenges and advancements in rheumatic disease. With its authoritative content, Rheumatic Disease Clinics of North America serves as a vital resource for those striving to improve patient care and clinical outcomes in the ever-evolving landscape of rheumatology research.
AKTUELLE RHEUMATOLOGIE
Transforming rheumatology through shared knowledge and research.AKTUELLE RHEUMATOLOGIE is a prominent German journal published by GEORG THIEME VERLAG KG, dedicated to advancing the field of rheumatology. Since its inception in 1978, this peer-reviewed journal has been a vital resource for professionals, researchers, and students engaged in the study and treatment of rheumatic diseases. With an ISSN of 0341-051X and an E-ISSN of 1438-9940, the journal provides a platform for sharing groundbreaking research, clinical studies, and reviews. Although classified in the fourth quartile (Q4) of rheumatology journals and ranked 67 out of 73 in its category according to Scopus, AKTUELLE RHEUMATOLOGIE continues to contribute to the discourse in rheumatology. Its comprehensive coverage of recent advancements and innovative approaches makes it an essential publication for anyone interested in the latest developments in the field.
Reumatismo
Advancing knowledge in rheumatology for a healthier future.Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.
Current Rheumatology Reviews
Shaping the future of rheumatology through rigorous reviews.Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.
Egyptian Rheumatology and Rehabilitation
Connecting researchers and clinicians for better patient outcomes.Egyptian Rheumatology and Rehabilitation is a distinguished open-access journal published by SpringerNature, dedicated to the vital field of rheumatology and rehabilitation. With an E-ISSN of 2090-3235 and a commitment to disseminating high-quality research, this journal serves as a platform for researchers, clinicians, and healthcare professionals to share innovative findings and enhance patient care in musculoskeletal disorders and related conditions. Since its transition to open access in 2013, the journal has prioritized accessibility, allowing a wider audience to engage with groundbreaking studies and clinical insights. By fostering a collaborative environment for knowledge exchange, Egyptian Rheumatology and Rehabilitation plays a crucial role in advancing the understanding of rheumatic diseases and improving rehabilitation strategies. The journal's commitment to quality and relevance in the evolving landscape of rheumatology makes it an invaluable resource for those pursuing excellence in research and practice.
Advances in Rheumatology
To innovate, educate, and transform rheumatology.Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.
ZEITSCHRIFT FUR RHEUMATOLOGIE
Innovating the future of rheumatology through scholarly discourse.ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.